newsfilter
← Latest News
Business Wire·

New Post Hoc Analysis from the HELIOS-B Phase 3 Study Shows Vutrisiran Improved Measures of Heart Structure and Function in Patients with ATTR-CM

− Analyses Presented at the American Heart Association Scientific Sessions 2025 Underscore Vutrisiran's Differentiated Profile – − Cardiovascular Magnetic Resonance (CMR) and Echocardiographic Analyses Demonstrate